Gina Mauro | Authors


Orca-T Reduces GVHD, Mortalities in Hematologic Malignancies

March 28, 2021

Data presented during the 2021 Transplantation and Cellular Therapy Meetings showed that treatment with Orca-T achieved a significant reduction in cases of graft-versus-host disease, an impressive GVHD relapse-free survival rate, and a lack of treatment-related mortalities while demonstrating scalability potential.

Pembrolizumab/Lenvatinib Leads to Survival Benefit in Previously Treated Advanced Endometrial Cancer, Regardless of MMR Status

March 20, 2021

Progression-free survival and overall survival were improved with pembrolizumab and lenvatinib when compared with chemotherapy in patients with advanced endometrial cancer who had received prior platinum-based chemotherapy in the phase 3 Study-309/KEYNOTE-775 trial.